Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma
暂无分享,去创建一个
A. Tolcher | N. Ibrahim | K. Papadopoulos | D. Rasco | A. Patnaik | M. Cornfeld | M. Motwani | G. Aktan | C. Becerra | A. Allred | K. Orford | G. Ferron-Brady | J. Gauvin | Geraldine Ferron-Brady